SCHEDULE 13D/AAccepted Jan 31, 9:31 PM ET
REVIVA PHARMACEUTICALS HOLDINGS, INC. SCHEDULE 13D/A
Accepted (ET)
9:31 PM
Jan 31, 2025
Filed
Jan 31, 2025
Documents
1
Size
18.5 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.